Find Your Next Book Thrillers N.Y.C. Literary Guide Nonfiction Spring Preview Fiction Spring Preview Advertisement Supported by Nonfiction In “Strangers in the Land,” Michael Luo tells the ...

Amid the worst U.S.-China trade clash in modern history, Michelle Xia thinks she has something Chinese that Americans will want. It isn’t a $3 T-shirt or an electronic gadget. It is a cancer ...

New Yorker editor Michael Luo writes that his new book, “Strangers in the Land: Exclusion, Belonging, and the Epic Story of the Chinese in America,” came into focus after a woman accosted him ...

Xia Baolong, the director of the Hong Kong and Macau Affairs Office, said in a video address that the up to 145 percent US tariffs on SAR goods showed "the US isn't after our tariffs – it is ...

Chinese actress Yidan Xia has been confirmed dead – nearly two years after her passing. She was 24 in 2023. The news has come as a shock to fans of the actress, who starred in the dramas The ...

Xia Baolong, director of the Hong Kong and Macau Affairs Office, also sought to reassure Hongkongers on Tuesday that the country would stand side by side with the city to face the US “bully” a ...

Michael Luo of ‘The New Yorker’ joins Russell to talk about his own experiences as a child of immigrants to America and as a Christian in a secular media ecosystem that doesn’t always “get ...

[Michale Mute, Standard] Professionals from the Luo community have threatened to sponsor an impeachment motion against Siaya Governor James Orengo for criticising the broad-based government.

Luo Bonian, Drawing Water from a Well, 1932. [Photo/Courtesy of Luo Bonian Art Foundation and Three Shadows +3 Gallery] Glinting Light: An Exploration of Luo Bonian's Photography, an ongoing ...

China’s top official overseeing Hong Kong and Macao, Xia Baolong, lashed out at the U.S. during a speech on national security, in which he linked 2019 pro-democracy protests in Hong Kong with ...

Help us continue bringing you unbiased news, in-depth investigations, and diverse perspectives. Your subscription keeps our mission alive and empowers us to provide high-quality, trustworthy ...

Bayer has added another phase 3 trial into its registration programme for oral Factor XIa inhibitor asundexian, signalling growing confidence in a drug that generated mixed results in phase 2.